Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2

Clin Infect Dis. 2023 Feb 8;76(3):e518-e521. doi: 10.1093/cid/ciac553.

Abstract

Little is known about the risk of multisystem inflammatory syndrome in children (MIS-C) with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in children aged 0-16 years were 56% lower (rate ratio [RR], 0.34 [95% confidence interval {CI}, .23-.50]) during prevaccine Delta, 66% lower (RR, 0.44 [95% CI, .28-.69]) during postvaccine Delta, and 95% lower (RR, 0.05 [95% CI, .02-.10]) during the Omicron period.

Keywords: COVID-19; MIS-C; PIMS-TS; SARS-CoV-2; coronavirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Child
  • Connective Tissue Diseases*
  • Coronavirus Infections*
  • Humans
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / epidemiology

Supplementary concepts

  • SARS-CoV-2 variants
  • pediatric multisystem inflammatory disease, COVID-19 related